14 articles
Oil prices fell nearly 2%, easing inflation concerns and boosting Wall Street gains, while Xenon Pharmaceuticals shares tumbled 28% after pausing clinical trials for a depression drug.
Biopharmaceutical firm Attovia Therapeutics targets a $731.5 million valuation in an upsized US IPO to raise $289 million for developing biologic therapies for immune-mediated diseases. Goldman Sachs
Nuclear startup Newcleo plans a Nasdaq listing via merger to raise up to $429 million for advanced reactor and fuel projects. SEC filings reveal widened losses and a collaboration with Oklo on a U.S.
Geopolitical tensions between the U.S. and Iran drove crude oil futures up over 2%, rattling investor sentiment and causing declines in major U.S. stock indices including the S&P 500 and Nasdaq.
Kardigan, a biotech developer of cardiovascular therapies, surged over 30% in its Nasdaq debut following a $400 million IPO. The funding will support late-stage clinical trials for experimental heart
Gas engine manufacturer Innio is launching an upsized $2.43 billion IPO on Nasdaq, driven by surging demand for its power generation systems supporting AI data centers and industrial energy infrastruc
US stock futures fell over 1% amid rising Treasury yields and inflation fears linked to Middle East tensions, with Brent crude prices surging nearly 3% on supply concerns.
Fervo Energy hit a $10.21 billion valuation after its Nasdaq debut, raising $1.89 billion to expand geothermal projects using advanced drilling. It aims to deliver carbon-free power for AI data center
US stock futures rose ahead of key data and Trump's China visit, where rare earth export curbs were discussed. Oil prices fell while investors monitor Federal Reserve policy shifts amidst rising infla
Bill Gates-backed Fervo Energy raised its IPO target to $1.8 billion, leveraging geothermal drilling tech to meet data center power demand. The Houston-based firm plans to list on Nasdaq by May 12 wit
New Fortress Energy received a Nasdaq deficiency notice due to its share price falling below $1 amid severe liquidity and debt issues. The LNG developer has 180 days to regain compliance or face delis
U.S. stock indices are on track for their best monthly performance since 2020, supported by strong earnings despite oil price spikes from Middle East tensions. Eli Lilly and Caterpillar led gains, whi
X-Energy raised $1.02 billion in its Nasdaq IPO, achieving an $11.9 billion valuation to deploy Xe-100 small modular reactors. The listing underscores rising demand for carbon-free energy from tech an
Kailera Therapeutics shares surged 62.5% in its Nasdaq IPO, raising $625 million amid intense competition in the weight-loss drug market dominated by GLP-1 therapies.
ChemBrief